Table 4.
All CHD Events | Hard CHD Events | All CVD Events | ||||
---|---|---|---|---|---|---|
Risk Factors* | ASCVD Risk† | Risk Factors* | ASCVD Risk† | Risk Factors* | ASCVD Risk† | |
Carotid Intima-Media Thickness ≤ 25th Percentile |
0.65 (0.04) | 0.53 (0.03) | 0.78 (0.04) | 0.64 (0.03) | 0.75 (0.04) | 0.61 (0.03) |
No Carotid Plaque | 0.84 (0.07) | 0.77 (0.06) | 0.88 (0.06) | 0.81 (0.05) | 0.88 (0.06) | 0.81 (0.05) |
Flow-Mediated Dilation ≥ 5% Change | 0.94 (0.10) | 0.90 (0.08) | 0.86 (0.16) | 0.81 (0.04) | 0.91 (0.15) | 0.87 (0.10) |
Ankle-Brachial Index > 0.9 – < 1.3 | 0.98 (0.02) | 0.98 (0.01) | 0.97 (0.03) | 0.95 (0.02) | 1.00 (0.02) | 0.99 (0.01) |
HsCRP < 2mg/L | 0.90 (0.03) | 0.91 (0.02) | 0.98 (0.01) | 0.96 (0.01) | 0.89 (0.04) | 0.87 (0.03) |
Homocysteine < 10µmol/L | 0.96 (0.02) | 0.90 (0.03) | 0.94 (0.03) | 0.89 (0.03) | 0.96 (0.02) | 0.91 (0.03) |
NT-ProBNP < 100pg/mL | 0.86 (0.10) | 0.92 (0.04) | 0.79 (0.12) | 0.83 (0.05) | 0.88 (0.09) | 0.90 (0.04) |
No Microalbuminura | 0.96 (0.05) | 0.95 (0.05) | 0.97 (0.05) | 0.96 (0.04) | 0.97 (0.05) | 0.95 (0.05) |
No Family History of CHD (any) | 0.76 (0.07) | 0.76 (0.06) | 0.78 (0.08) | 0.77 (0.07) | 0.81 (0.06) | 0.80 (0.05) |
No Family History of Premature CHD | 0.97 (0.08) | 0.96 (0.06) | 0.99 (0.01) | 0.96 (0.05) | 0.96 (0.07) | 0.95 (0.05) |
No Metabolic Syndrome | 0.90 (0.08) | 0.85 (0.04) | 0.91 (0.08) | 0.87 (0.03) | 0.91 (0.08) | 0.85 (0.04) |
Healthy Lifestyle | 0.90 (0.13) | 0.84 (0.04) | 0.87 (0.08) | 0.81 (0.01) | 0.98 (0.16) | 0.90 (0.05) |
Age, gender, smoking status, diabetes, total and HDL cholesterol, systolic blood pressure, hypertension medication use and race/ethnicity.
10-year atherosclerotic ASCVD risk, calculated using the ACC/AHA 2013 Pooled Cohort Equations.
CHD indicates coronary heart disease; CVD, cardiovascular disease; ASCVD, atherosclerotic cardiovascular disease; HsCRP, high sensitivity C-reactive protein; and NT-ProBNP, N-terminal pro-brain natriuretic peptide.